ANDA 83287, held by Watson Laboratories. Procainamide Hydrochloride.
As of Nov 21, 2026, ANDA 83287 (Procainamide Hydrochloride), held by Watson Laboratories, was first approved by FDA on Jun 3, 1977, with 17 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 3, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Procainamide Hydrochloride250MG · capsule;oral | Procainamide Hydrochloride | Discontinued |
| Jul 29, 1998 | Supplement 50Labeling | Approved | None posted |
| Feb 24, 1992 | Supplement 49Labeling | Approved | None posted |
| Aug 7, 1991 | Supplement 47Manufacturing | Approved | None posted |
| Jan 28, 1991 | Supplement 48Manufacturing | Approved | None posted |
| Jun 29, 1990 | Supplement 46Manufacturing | Approved | None posted |
| Nov 1, 1988 | Supplement 45Labeling | Approved | None posted |
| Dec 14, 1987 | Supplement 44Manufacturing | Approved | None posted |
| Nov 19, 1987 | Supplement 43Manufacturing | Approved | None posted |
| Nov 19, 1987 | Supplement 42Manufacturing | Approved | None posted |
| Nov 19, 1987 | Supplement 41Manufacturing | Approved | None posted |
| Dec 18, 1985 | Supplement 39Manufacturing | Approved | None posted |
| Dec 18, 1985 | Supplement 38Manufacturing | Approved | None posted |
| Dec 18, 1985 | Supplement 37Manufacturing | Approved | None posted |
| Jun 3, 1985 | Supplement 36Manufacturing | Approved | None posted |
| Jun 3, 1985 | Supplement 35Manufacturing | Approved | None posted |
| Dec 8, 1983 | Supplement 34Manufacturing | Approved | None posted |
| Feb 28, 1983 | Supplement 33Manufacturing | Approved | None posted |
| Jun 3, 1977 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters